AIDS-defining clinical condition
AIDS-defining clinical conditions is the list of diseases published by the Centers for Disease Control and Prevention that are associated with AIDS and used worldwide as a guideline for AIDS diagnosis. CDC exclusively uses the term AIDS-defining clinical conditions, but the other terms remain in common use.
This list governs the US government's classification of HIV disease. This is to allow the government to handle epidemic statistics and define who receives US government assistance. However, considerable variation exists in the relative risk of death following different AIDS-defining clinical conditions.
Definition
According to the CDC definition, a patient has AIDS if they are infected with HIV and have either:- a CD4+ T-cell count below 200 cells/μL
- a CD4+ T-cell percentage of total lymphocytes of less than 14%
- or one of the defining illnesses.
- undergone high-dose corticoid therapy or other immunosuppressive/cytotoxic therapy in the three months before the onset of the indicator disease
- been diagnosed with Hodgkin's disease, non-Hodgkin's lymphoma, lymphocytic leukemia, multiple myeloma, or any cancer of lymphoreticular or histiocytic tissue, or angioimmunoblastic lymphoadenopathy
- or been diagnosed with a genetic immunodeficiency syndrome atypical of HIV infection, such as one involving hypogammaglobulinemia.
Defining illnesses
2008 definition
Are the following:- Candidiasis of bronchi, trachea, or lungs
- Candidiasis esophageal
- Coccidioidomycosis, disseminated or extrapulmonary
- Cryptococcosis, extrapulmonary
- Cryptosporidiosis, chronic intestinal for longer than 1 month
- Cytomegalovirus disease
- Cytomegalovirus retinitis
- Encephalopathy
- Herpes simplex: chronic ulcer ; or bronchitis, pneumonitis, or esophagitis
- Histoplasmosis, disseminated or extrapulmonary
- Isosporiasis, chronic intestinal
- Kaposi's sarcoma
- Lymphoma, Burkitt's
- Lymphoma, immunoblastic
- Lymphoma, primary, of brain
- Mycobacterium avium complex or Mycobacterium kansasii, disseminated or extrapulmonary
- Mycobacterium, other species, disseminated or extrapulmonary
- Mycobacterium tuberculosis, any site
- Pneumocystis jirovecii pneumonia
- Progressive multifocal leukoencephalopathy
- Salmonella sepsis
- Toxoplasmosis of the brain
- Tuberculosis, disseminated
- Wasting syndrome due to HIV
Added in 1993
- Cervical cancer
- Mycobacterium tuberculosis, any site
- Pneumonia
Children < 13 years
- Bacterial infections, multiple or recurrent
- Lymphoid interstitial pneumonia or pulmonary lymphoid hyperplasia complex
History
It has been suggested that other conditions should be included in other countries.
Common Defining Conditions
Kaposi's Sarcoma
Kaposi's Sarcoma is an extremely common disease that arises in AIDS patients and HIV-infected individuals. The condition is characterized by large purple lesions on the skin and mouth. KS presents itself differently for everyone affected by it, and its symptoms and progression varies from person to person as well. There are four different populations that are at risk for KS, all of which are caused by infection with human herpesvirus 8. In the United States, almost every case of Kaposi's Sarcoma is indirectly caused by HIV infection. The disease is the most common among male homosexuals, presumably because human herpesvirus 8 exists with the most prevalence within this population.The remaining types of KS are known as Classic, Endemic, and Transplant-related Kaposi's Sarcoma. Classic KS is common in regions of the Middle East, where herpesvirus 8 is fairly prevalent. KS occurrences in these regions are mainly found in older men, which is thought to be due to the natural decline of the immune system's strength when we age. Endemic KS presents itself the same way, but is a result of many people in certain regions of Africa being infected with human herpesvirus 8. In contrast to older men being affected in Classical infections, Endemic KS mainly affects young children, as the virus is transferred from mother to child via saliva. The final type of KS, transplant-related, is theoretically capable of manifesting in anyone. Transplant patients must take very strong immunosuppressant drugs to ensure that the body does not reject their new heart, liver, etc. However, a consequence of this is, of course, that their immune system becomes quite weak, and therefore very susceptible to infections. In a similar manner to how HIV contributes to KS, transplant patients are also at high risk for it, especially if the transplant was performed in a country where human herpesvirus 8 is endemic. In recent years, however, incidences of Kaposi's sarcoma in the United States have dwindled so much that physicians today often fail to consider it as a possibility when making diagnoses.